NITISINONE
| Brand name | NITYR |
|---|---|
| Active ingredient | NITISINONE |
| Strength | 10MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10328029 | January 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.